This batch of results is excellent, my favourite parts:
1. Keytruda and Cavatak seem to be getting good results in metastatic bladder cancer and non small cell lung cancer (I am sure this one is the big value driver for VLA)
2. The mouse results are outstanding for Cavatak - combinations are consistently better with Cavatak than without.
Will be very interesting to see what Mr Market makes of the new results!
- Forums
- ASX - By Stock
- Ann: Viralytics to Present at 2017 SITC Annual Meeting
This batch of results is excellent, my favourite parts: 1....
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)